Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Fresenius Medical Care AG (FMS) Equity Income: 2009-2024

Historic Equity Income for Fresenius Medical Care AG (FMS) over the last 16 years, with FY2024 value amounting to $146.0 million.

  • Fresenius Medical Care AG's Equity Income fell 2044.79% to -$54.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$190.0 million, marking a year-over-year decrease of 3860.48%. This contributed to the annual value of $146.0 million for FY2024, which is 1140.7% up from last year.
  • Fresenius Medical Care AG's Equity Income amounted to $146.0 million in FY2024, which was up 1140.7% from $131.0 million recorded in FY2023.
  • Fresenius Medical Care AG's 5-year Equity Income high stood at $146.0 million for FY2024, and its period low was $70.2 million during FY2022.
  • Over the past 5 years, Fresenius Medical Care AG's median Equity Income value was $107.9 million (recorded in 2020), while the average stood at $112.1 million.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Equity Income plummeted by 3347.25% in 2022, and later skyrocketed by 8678.96% in 2023.
  • Annual analysis of 5 years shows Fresenius Medical Care AG's Equity Income stood at $107.9 million in 2020, then fell by 2.29% to $105.4 million in 2021, then tumbled by 33.47% to $70.2 million in 2022, then surged by 86.79% to $131.0 million in 2023, then increased by 11.41% to $146.0 million in 2024.
  • Its last three reported values are $146.0 million in FY2024, $131.0 million for FY2023, and $70.2 million during FY2022.